SEC Filing Summary: AXON ENTERPRISE, INC.
Business Context and Reporting Period
This filing is a Form 13F Information Table submitted by AXON ENTERPRISE, INC. for the reporting period ending March 31, 2026. The document discloses institutional investment holdings rather than the company's own financial performance.
Key Financial Metrics
The filing text does not provide revenue, profit, cash flow, margins, debt, or liquidity metrics for Axon Enterprise, Inc. Form 13F filings report on securities held by the filer, not the filer's internal financial statements.
Material Changes and Holdings
The filing discloses a specific equity position held by the manager:
- Issuer: CELLEBRITE DI LTD
- Security: Ordinary Shares (CUSIP: M2197Q107)
- Shares Held: 18,051,979
- Value: $1,310,013
- Voting Authority: Sole
No prior period data is included in this text to determine material changes in this specific position.
Guidance, Outlook, and Risks
The filing text does not contain management commentary, guidance, outlook, or risk factors regarding Axon Enterprise, Inc. or the underlying holdings. It is a regulatory disclosure of portfolio composition.
Investor Verification Checklist
- Verify the total portfolio value of Axon Enterprise, Inc. by reviewing the complete Form 13F, as this text only lists one position.
- Confirm the valuation date of the $1,310,013 holding to ensure it aligns with the March 31, 2026 period end.
- Check for additional filings (e.g., 10-K, 10-Q) to obtain Axon Enterprise's actual financial performance metrics.
- Validate the CUSIP M2197Q107 against current market data for Cellebrite DI Ltd.